These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 8819002)
1. Novel approach to the analysis of in vitro-in vivo relationships. Polli JE; Crison JR; Amidon GL J Pharm Sci; 1996 Jul; 85(7):753-60. PubMed ID: 8819002 [TBL] [Abstract][Full Text] [Related]
2. Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro-in vivo correlation. Hou J; He X; Xu X; Shi X; Xu Y; Liu C Drug Dev Ind Pharm; 2012 Nov; 38(11):1305-12. PubMed ID: 22296178 [TBL] [Abstract][Full Text] [Related]
3. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets. Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615 [TBL] [Abstract][Full Text] [Related]
4. Establishment of novel prediction system of intestinal absorption in humans using human intestinal tissues. Miyake M; Toguchi H; Nishibayashi T; Higaki K; Sugita A; Koganei K; Kamada N; Kitazume MT; Hisamatsu T; Sato T; Okamoto S; Kanai T; Hibi T J Pharm Sci; 2013 Aug; 102(8):2564-71. PubMed ID: 23686795 [TBL] [Abstract][Full Text] [Related]
5. A method of determining the in vivo drug release rate constant of sustained-release preparation. Sun H; Chow MS Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910 [TBL] [Abstract][Full Text] [Related]
6. Is the full potential of the biopharmaceutics classification system reached? Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971 [TBL] [Abstract][Full Text] [Related]
7. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model. Sobol E; Bialer M Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218 [TBL] [Abstract][Full Text] [Related]
8. Single-pass intestinal perfusion to establish the intestinal permeability of model drugs in mouse. Escribano E; Sala XG; Salamanca J; Navarro CR; Regué JQ Int J Pharm; 2012 Oct; 436(1-2):472-7. PubMed ID: 22814225 [TBL] [Abstract][Full Text] [Related]
9. Regional intestinal drug permeation: biopharmaceutics and drug development. Lennernäs H Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845 [TBL] [Abstract][Full Text] [Related]
10. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans. Velický M; Tam KY; Dryfe RA Eur J Pharm Sci; 2011 Oct; 44(3):299-309. PubMed ID: 21864679 [TBL] [Abstract][Full Text] [Related]
11. Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats. Saitoh R; Miyayama T; Mitsui T; Akiba Y; Higashida A; Takata S; Kawanishi T; Aso Y; Itoh Z; Omura S Xenobiotica; 2007 Dec; 37(12):1421-32. PubMed ID: 17926229 [TBL] [Abstract][Full Text] [Related]
12. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Azarmi Y; Islambolchilar Z; Barzegar S; Barzegar-Jalali M J Pharm Pharm Sci; 2007; 10(3):368-79. PubMed ID: 17727800 [TBL] [Abstract][Full Text] [Related]
13. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Prabhu S; Ortega M; Ma C Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087 [TBL] [Abstract][Full Text] [Related]
14. Prediction of oral drug absorption in humans by theoretical passive absorption model. Obata K; Sugano K; Saitoh R; Higashida A; Nabuchi Y; Machida M; Aso Y Int J Pharm; 2005 Apr; 293(1-2):183-92. PubMed ID: 15778056 [TBL] [Abstract][Full Text] [Related]
15. Critical dissolution tests of oral systems based on statistically designed experiments. III. In vitro/in vivo correlation for multiple-unit capsules of paracetamol based on PLS modeling. Abuzarur-Aloul R; Gjellan K; Sjölund M; Graffner C Drug Dev Ind Pharm; 1998 Apr; 24(4):371-83. PubMed ID: 9876598 [TBL] [Abstract][Full Text] [Related]
16. Dissolution specifications based on release rates. Elkoshi Z J Pharm Sci; 1999 Apr; 88(4):434-44. PubMed ID: 10187754 [TBL] [Abstract][Full Text] [Related]
17. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data. Donato EM; Martins LA; Fröehlich PE; Bergold AM J Pharm Biomed Anal; 2008 Jul; 47(3):547-52. PubMed ID: 18403160 [TBL] [Abstract][Full Text] [Related]
19. A non-binary biopharmaceutical classification of drugs: the ABΓ system. Macheras P; Karalis V Int J Pharm; 2014 Apr; 464(1-2):85-90. PubMed ID: 24456673 [TBL] [Abstract][Full Text] [Related]
20. Computational prediction of oral drug absorption based on absorption rate constants in humans. Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]